Curebase is a Healthtech company based in New York, NY. It has raised $59M in total funding. Latest round: Series B.
Curebase funding overview
Curebase is a Healthtech company based in New York, NY. Curebase has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2022. The round record for Curebase runs through 2022; nothing later has been disclosed. Investors on record include Industry Ventures, Gilead Sciences, Y Combinator. 3 distinct backers are named across the disclosed rounds.
Curebase at a glance
Total raised
$59M
Latest round
Series B
Latest round date
May 2022
Industry
Healthtech
Headquarters
New York, NY
Notable investors
Industry Ventures, Gilead Sciences, Y Combinator
Frequently asked about Curebase funding
How much has Curebase raised?
Curebase has raised $59M in total disclosed funding across the rounds on record.
Who has invested in Curebase?
Industry Ventures, Gilead Sciences, Y Combinator are named among the investors backing Curebase.
What was the latest Curebase funding round?
The most recent disclosed round is a Series B, announced in May 2022.
Where is Curebase based?
Curebase is based in New York, NY.
What sector does Curebase operate in?
Curebase is tracked under Healthtech from New York, NY, with $59M in disclosed funding.
When did Curebase last raise?
The last disclosed Curebase round closed in May 2022 at Series B.
Totals shown for Curebase aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies in New York and the investors behind them below.
